“Marijuana use under state marijuana programs or other non-prescription sources does not qualify as a ‘legitimate medical explanation’ under 49 CFR § 40.137(a),” the memo reads.
NORML is an advocacy organization dedicated to advancing the legalization and responsible use of marijuana by adults. The site serves as both a resource and a platform for cannabis consumers, aiming to influence public opinion and policy to ensure safe, convenient, and affordable access to high-quality marijuana. Its mission-driven content focuses on cannabis-related issues, including legal policy developments, government announcements, regulatory changes, and broader discussions about cannabis and psychedelics.
The primary audience includes advocates for drug policy reform, cannabis consumers, policymakers interested in regulation changes, researchers following legislative trends in cannabis law, as well as the general public seeking reliable information on marijuana legalization efforts. NORML’s readership often consists of individuals who are engaged with or affected by ongoing debates around drug laws.
NORML covers its topics through a mix of data-driven reporting—citing official data sources—alongside press releases from relevant organizations or authorities. The platform also features opinion editorials that reflect advocacy perspectives and expert commentary on evolving legal frameworks. This approach ensures readers receive both factual updates and informed viewpoints regarding the shifting landscape of cannabis legislation.
Content is distributed primarily via online digital print formats and an active blog presence. This multi-platform strategy allows NORML to reach audiences through timely news updates as well as more in-depth editorial pieces tailored for those invested in the future of cannabis policy reform.
